Position in BEAM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,538,030
+$1,863,375 QoQ
Shares Held
132,227
+17.8% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. BEAM ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in BEAM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,538,030 | 132,227 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,674,655 | 112,239 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,636,836 | 131,199 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,490,705 | 143,828 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,574,837 | 151,372 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,757,714 | 141,204 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,130,578 | 126,233 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,114,072 | 127,105 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,106,091 | 132,569 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,601,492 | 109,004 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,836,650 | 104,212 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,537,178 | 105,496 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,036,032 | 95,084 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,692,967 | 87,948 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,384,579 | 86,540 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,047,351 | 84,957 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,949,469 | 76,194 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,105,774 | 54,202 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,128,977 | 51,813 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,519,386 | 51,941 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,272,167 | 48,731 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,497,828 | 43,701 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,774,788 | 46,237 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $911,752 | 37,033 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $410,116 | 14,647 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $210,474 | 11,693 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||